Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karkoszka, H.
Right arrow Articles by Kokot, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karkoszka, H.
Right arrow Articles by Kokot, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 8 2077-2080, Copyright © 1998 by Oxford University Press


PRELIMINARY REPORTS

Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients?

H Karkoszka, J Chudek, P Strzelczyk, A Wiecek, H Schmidt-Gayk, E Ritz and F Kokot
Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian University School of Medicine, Katowice, Poland; Department of Nephrology, Ruprecht-Karl University and Endocrine Laboratory, Laboratory Group, Heidelberg, Germany; Correspondence to: F Kokot, Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian University School of Medicine, ul. Francuska 20/24, 40-027 Katowice, Poland

Background. It has been suggested that the vitamin D receptor (VDR) gene BsmI-polymorphism is a genetic determinant of bone metabolism. Design. To test this hypothesis, the relationship between VDR genotypes, bone mineral density (baseline and after 18 months) and parameters of calcium metabolism and bone turnover were investigated prospectively in 88 haemodialysed patients not receiving active vitamin D metabolites. Methods. Whole body, lumbar spine and femoral neck bone mineral density (BMD) were assessed by dual energy X-ray absorptiometry (DEXA). In addition calcium, phosphorus, 25(OH)D3, 1,25(OH)2D3, osteocalcin serum concentrations, alkaline phosphatase activity and intact, 1,84 PTH levels were measured. Results. VDR genotype BB, Bb and bb were found in 27, 49 and 24% of patients. Initial BMD (g/cm2) of whole body, lumbar spine and femoral neck did not differ between genotypes (whole body: BB 1.055 ± 0.120, Bb 1.082 ± 0.102, bb 1.128 ± 0.120; lumbar spine: BB 1.075 ± 0.199, Bb 1.079 ± 0.185, bb 1.099 ± 0.170; femoral neck: BB 0.808 ± 0.160, Bb 0.862 ± 0.127, bb 0.842 ± 0.125; mean ± SD), but the decrease of whole body and femoral neck BMD during 18 months was significantly (P < 0.02) different between the genotype groups (whole body: BB -0.048 ± 0.028, Bb -0.031 ± 0.029, bb -0.024 ± 0.023; femoral neck BB -0.044 ± 0.069, Bb -0.032 ± 0.081, bb -0.012 ± 0.029 g/cm2). Conclusions. This preliminary study suggests faster mineral loss in BB genotype of VDR in haemodialysed patients. Keywords: bone mineral density; haemodialysis; vitamin D receptor gene polymorphism
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
J R Ortlepp, R Hoffmann, F Ohme, J Lauscher, F Bleckmann, and P Hanrath
The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis
Heart, June 1, 2001; 85(6): 635 - 638.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. A. Eisman
Genetics of Osteoporosis
Endocr. Rev., December 1, 1999; 20(6): 788 - 804.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.